Uterine leiomyosarcoma well-controlled with eribulin mesylate
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/article/10.1007/s13691-018-0350-1/fulltext.html
Reference17 articles.
1. Schöffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma. Lancet 387:1629–1637
2. WHO classification of tumors of Female Reproductive Organs; 2014:139–141
3. Seagle BL, Sobecki-Rausch J, Strohl AE et al (2017) Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study. Gynecol Oncol 145:61–70
4. Omura GA, Major FJ, Blessing JA et al (1983) A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52:626–632
5. Look KY, Sandler A, Blessing JA et al (2004) PhaseII trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study. Gynecol Oncol 92:644–647
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma;European Journal of Pharmacology;2024-05
2. A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years;Frontiers in Oncology;2024-02-12
3. Effects of Usnic Acid on Cytotoxicity, Colony Formation and Migration in SK-UT-1 Human Uterine Leiomyosarcoma Cells;Süleyman Demirel Üniversitesi Fen Edebiyat Fakültesi Fen Dergisi;2023-11-23
4. Achievement of a durable response with eribulin for relapsed cardiac metastasis of uterine leiomyosarcoma after surgery: a case report and literature review;Annals of Palliative Medicine;2023-01
5. Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells;Journal of Pharmacological Sciences;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3